Breast Cancer

TILs reveal the immune signal in breast cancer

Evidence is growing to support the idea that the immune system plays a role in some breast cancers and that tumour infiltrating lymphocytes (TILs) can predict prognosis and response to therapy. Given TILs can be easily estimated on hematoxylin and eosin stains, they offer a relatively simple biomarker that can potentially help direct therapy. According ...

Already a member?

Login to keep reading.

© 2022 the limbic